Showing results (1-10 of 13) with videos related to
Sort By:
Pageof 2
Journal of Medicinal Chemistry|January 5, 1996
Effect of linking bridge modifications on the antipsychotic profile of some phthalimide and isoindolinone derivativesM H Norman, D J Minick, G C RigdonJournal of Medicinal Chemistry|October 29, 1993
Conformationally restricted analogues of remoxipride as potential antipsychotic agentsM H Norman, J L Kelley, E B HollingsworthJournal of Medicinal Chemistry|March 1, 1996
Structure-activity relationships of a series of substituted benzamides: potent D2/5-HT2 antagonists and 5-HT1a agonists as neuroleptic agentsM H Norman, G C Rigdon, W R Hall, et al.Journal of Medicinal Chemistry|November 22, 1996
Synthesis and evaluation of heterocyclic carboxamides as potential antipsychotic agentsM H Norman, F Navas, J B Thompson, et al.Journal of Medicinal Chemistry|August 5, 1994
Cyclic benzamides as mixed dopamine D2/serotonin 5-HT2 receptor antagonists: potential atypical antipsychotic agentsM H Norman, G C Rigdon, F Navas, et al.Bioorganic & Medicinal Chemistry|July 29, 1998
Analogues of the potential antipsychotic agent 1192U90: amide modificationsF Navas, F L Tang, L T Schaller, et al.Life Sciences|January 1, 1995
Is clozapine selective for the dopamine D4 receptor?M J Durcan, G C Rigdon, M H Norman, et al.Journal of Medicinal Chemistry|June 29, 2001
Synthesis and structure-activity relationships of trisubstituted phenyl urea derivatives as neuropeptide Y5 receptor antagonistsC Fotsch, J D Sonnenberg, N Chen, et al.Neuroscience|July 22, 2008
Delayed administration of a potent cyclin dependent kinase and glycogen synthase kinase 3 beta inhibitor produces long-term neuroprotection in a hypoxia-ischemia model of brain injuryC D Cowper-Smith, G J A Anger, E Magal, et al.Brain Research|June 8, 2000
Behavioral characterization of neuropeptide Y knockout miceA W Bannon, J Seda, M Carmouche, et al.Pageof 2